Calcific Aortic Stenosis: Lessons Learned from Experimental and Clinical Studies

Overview

Journal Arterioscler Thromb Vasc Biol

Date 2008 Nov 22

PMID 19023094

Citations 50

Authors

Nalini M Rajamannan

Affiliations

Soon will be listed here.

Abstract

Calcific aortic stenosis is the most common indication for surgical valve replacement in the United States. For years this disease has been described as a passive degenerative process during which serum calcium attaches to the valve surface and binds to the leaflet to form nodules. Therefore, surgical treatment of this disease has been the approach toward relieving outflow obstruction in these patients. Recent studies demonstrate an association between atherosclerosis and its risk factors for aortic valve disease. In 2008, there are increasing number of epidemiology and experimental studies to provide evidence that this disease process is not a passive phenomena. There is an active cellular process that develops within the valve leaflet and causes a regulated bone formation to develop. If the atherosclerotic hypothesis is important in the initiation of aortic stenosis, then treatments used in slowing the progression of atherosclerosis may be effective in patients with aortic valve disease. This review will discuss the pathogenesis and the potential for medical therapy in the management of patients with calcific aortic stenosis by examining the lessons provided from the experimental research.

Citing Articles

Association between Serum Testosterone and Aortic Valve Stenosis: A Prospective Cohort Study.

Laukkanen J, Lavie C, Kunutsor S J Cardiovasc Dev Dis. 2023; 10(11).

PMID: 37998512 PMC: 10671969. DOI: 10.3390/jcdd10110454.

Development and analysis of a comprehensive diagnostic model for aortic valve calcification using machine learning methods and artificial neural networks.

Xiong T, Chen Y, Han S, Zhang T, Pu L, Fan Y Front Cardiovasc Med. 2022; 9:913776.

PMID: 36531717 PMC: 9751025. DOI: 10.3389/fcvm.2022.913776.

Sex-dependent expression of neutrophil gelatinase-associated lipocalin in aortic stenosis.

Jover E, Matilla L, Martin-Nunez E, Garaikoetxea M, Navarro A, Fernandez-Celis A Biol Sex Differ. 2022; 13(1):71.

PMID: 36510294 PMC: 9743642. DOI: 10.1186/s13293-022-00480-w.

Arterial stiffness in aortic stenosis - complex clinical and prognostic implications.

Albu A, Para I, Bidian C Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022; 166(4):369-379.

PMID: 36128849 DOI: 10.5507/bp.2022.040.

Lipoprotein(a), a Lethal Player in Calcific Aortic Valve Disease.

Hu J, Lei H, Liu L, Xu D Front Cell Dev Biol. 2022; 10:812368.

PMID: 35155427 PMC: 8830536. DOI: 10.3389/fcell.2022.812368.

References

Mohler 3rd E, Adam L, McClelland P, Graham L, Hathaway D . Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol. 1997; 17(3):547-52. DOI: 10.1161/01.atv.17.3.547. View

Nordstrom P, Glader C, Dahlen G, Birgander L, Lorentzon R, Waldenstrom A . Oestrogen receptor alpha gene polymorphism is related to aortic valve sclerosis in postmenopausal women. J Intern Med. 2003; 254(2):140-6. DOI: 10.1046/j.1365-2796.2003.01179.x. View

Aronow W, Ahn C, Kronzon I . Association of mitral annular calcium with symptomatic peripheral arterial disease in older persons. Am J Cardiol. 2001; 88(3):333-4. DOI: 10.1016/s0002-9149(01)01657-5. View

OBrien K, Shavelle D, Caulfield M, McDonald T, Otto C, Probstfield J . Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation. 2002; 106(17):2224-30. DOI: 10.1161/01.cir.0000035655.45453.d2. View

Weiss R, Ohashi M, Miller J, Young S, Heistad D . Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation. 2006; 114(19):2065-9. DOI: 10.1161/CIRCULATIONAHA.106.634139. View

Bonow R, Carabello B, Kanu C, de Leon Jr A, Freed M, Gaasch W . ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the.... Circulation. 2006; 114(5):e84-231. DOI: 10.1161/CIRCULATIONAHA.106.176857. View

Jian B, Jones P, Li Q, Mohler 3rd E, Schoen F, Levy R . Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. Am J Pathol. 2001; 159(1):321-7. PMC: 1850407. DOI: 10.1016/S0002-9440(10)61698-7. View

Arishiro K, Hoshiga M, Negoro N, Jin D, Takai S, Miyazaki M . Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits. J Am Coll Cardiol. 2007; 49(13):1482-9. DOI: 10.1016/j.jacc.2006.11.043. View

Shao J, Cheng S, Pingsterhaus J, Charlton-Kachigian N, Loewy A, Towler D . Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest. 2005; 115(5):1210-20. PMC: 1077175. DOI: 10.1172/JCI24140. View

10.

Sarphie T . Surface responses of aortic valve endothelia from diet-induced, hypercholesterolemic rabbits. Atherosclerosis. 1985; 54(3):283-99. DOI: 10.1016/0021-9150(85)90122-4. View

11.

Probst V, Scouarnec S, Legendre A, Jousseaume V, Jaafar P, Nguyen J . Familial aggregation of calcific aortic valve stenosis in the western part of France. Circulation. 2006; 113(6):856-60. DOI: 10.1161/CIRCULATIONAHA.105.569467. View

12.

Rajamannan N, Subramaniam M, Rickard D, Stock S, Donovan J, Springett M . Human aortic valve calcification is associated with an osteoblast phenotype. Circulation. 2003; 107(17):2181-4. PMC: 3922288. DOI: 10.1161/01.CIR.0000070591.21548.69. View

13.

Drolet M, Arsenault M, Couet J . Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol. 2003; 41(7):1211-7. DOI: 10.1016/s0735-1097(03)00090-1. View

14.

OBrien K, Kuusisto J, REICHENBACH D, Ferguson M, Giachelli C, Alpers C . Osteopontin is expressed in human aortic valvular lesions. Circulation. 1995; 92(8):2163-8. DOI: 10.1161/01.cir.92.8.2163. View

15.

Briand M, Lemieux I, Dumesnil J, Mathieu P, Cartier A, Despres J . Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J Am Coll Cardiol. 2006; 47(11):2229-36. DOI: 10.1016/j.jacc.2005.12.073. View

16.

Ngo D, Heresztyn T, Mishra K, Marwick T, Horowitz J . Aortic stenosis is associated with elevated plasma levels of asymmetric dimethylarginine (ADMA). Nitric Oxide. 2006; 16(2):197-201. DOI: 10.1016/j.niox.2006.10.003. View

17.

Ortlepp J, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P . The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart. 2001; 85(6):635-8. PMC: 1729782. DOI: 10.1136/heart.85.6.635. View

18.

Sprecher D, Schaefer E, Kent K, GREGG R, Zech L, Hoeg J . Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol. 1984; 54(1):20-30. DOI: 10.1016/0002-9149(84)90298-4. View

19.

Caira F, Stock S, Gleason T, McGee E, Huang J, Bonow R . Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol. 2006; 47(8):1707-12. PMC: 3951851. DOI: 10.1016/j.jacc.2006.02.040. View

20.

Demer L . Cholesterol in vascular and valvular calcification. Circulation. 2001; 104(16):1881-3. View